Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
6.75    0.00 (0.00%)
Bid:
6.70
Ask:
6.80
Spread: 0.10 (1.493%)
Market Cap: £2.96m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Directorate Change

16 Oct 2012 07:00

RNS Number : 7425O
Feedback PLC
16 October 2012
 



16 October 2012

 

Feedback plc

("Feedback" or "the Company")

 

Directorate Change

 

It is with regret that Feedback announces that David Barton has resigned as non-executive director with immediate effect due to health reasons.

 

Commenting on Mr Barton's departure from the Company Nick Shepheard, Chairman and Chief Executive, said: "I would like to thank David for his support, hard work and contribution to Feedback since he joined the Company in 2007. I am very sorry that he has had to leave us in these circumstances and I wish him all the best for the future."

 

 

For further information contact:

 

Feedback plc

Tel: 01825 764 098

Nick Shepheard

Merchant Securities Limited

Simon Clements/Lindsay Mair

Tel: 020 7628 2200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAMABFTMBTBBAT
Date   Source Headline
27th Apr 20202:00 pmRNSPrice Monitoring Extension
27th Apr 202011:05 amRNSSecond Price Monitoring Extn
27th Apr 202011:00 amRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSGrant of Options
20th Apr 20207:00 amRNSBleepa rolled out at PAH NHS Trust for Covid-19
26th Mar 20203:52 pmRNSFeedback Medical to offer Bleepa for COVID-19
18th Feb 20207:00 amRNSInterim Results
3rd Feb 202012:21 pmRNSAppointment of Non-Executive Director
21st Jan 202010:30 amRNSChange of Registered Office
13th Jan 20207:00 amRNSLicence agreement with Imaging Engineering
19th Nov 20197:00 amRNSResult of AGM
18th Nov 20197:01 amRNSAGM Statement
18th Nov 20197:00 amRNSFirst Bleepa pilot study initiated with NHS Trust
24th Oct 20198:28 amRNSFinal Results: Revenue up 23%
17th Oct 20197:00 amRNSUpdate re Bleepa®
27th Sep 20192:52 pmRNSStatement re share price
4th Sep 20197:00 amRNSBleepa - the clinical messaging app - at NHS Expo
3rd Sep 20199:46 amRNSHolding(s) in Company
2nd Sep 201912:24 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSHolding(s) in Company
30th Aug 20195:00 pmRNSTotal Voting Rights
29th Aug 20192:06 pmRNSResult of General Meeting
29th Aug 20197:00 amRNSBoard Changes
13th Aug 20192:45 pmRNSPosting of Circular and Notice of General Meeting
12th Aug 20197:00 amRNSProposed placing and subscription to raise £2m
7th Aug 201910:47 amRNSStatement re Online Commentary
26th Jul 201912:03 pmRNSBleepa - revolutionising clinical messaging
10th Jul 20197:00 amRNSOutcome of strategic review and trading update
10th Jun 20199:28 amRNSHolding(s) in Company
7th Jun 201910:07 amRNSHolding(s) in Company
25th Apr 20197:00 amRNSTrading update
9th Apr 20197:00 amRNSFeedback Medical CEO appointed Feedback plc CEO
14th Feb 20197:00 amRNSFeedback Medical appoints Dr Tom Oakley as CEO
24th Jan 20197:00 amRNSHalf-year Results
23rd Jan 20192:02 pmRNSResult of AGM
30th Nov 20185:00 pmRNSTotal Voting Rights
29th Nov 20182:37 pmRNSFinal Results
22nd Nov 201812:59 pmRNSFeedback retains industry standard certification
19th Nov 20182:56 pmRNSDirector/PDMR Shareholding
19th Nov 201811:49 amRNSHolding(s) in Company
16th Nov 20189:16 amRNSHolding(s) in Company
15th Nov 201811:35 amRNSResult of General Meeting
1st Nov 20183:11 pmRNSHolding(s) in Company
31st Oct 20185:00 pmRNSTotal Voting Rights
31st Oct 20184:15 pmRNSHolding(s) in Company
29th Oct 20182:44 pmRNSNotice of General Meeting
25th Oct 20187:00 amRNSProposed placing and subscription to raise £1.375m
22nd Oct 20187:00 amRNSExpansion of European customer base
3rd Oct 20187:00 amRNSTrading update
1st Oct 20187:00 amRNSAppointment of Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.